BERLIN, 16 October 2018 - Eleven heads of the world’s leading health and development organizations today signed a landmark commitment to find new ways of working together to accelerate progress towards achieving the United Nations’ Sustainable Development Goals.
Coordinated by the World Health Organization, the initiative unites the work of 11 organizations, with others set to join in the next phase.
The 2018 United Nations General Assembly High-Level Meeting (HLM) on Tuberculosis and the current revision of the Roadmap for childhood tuberculosis together present an important moment to consolidate and advance advocacy, commitment, resource mobilization and joint efforts by all stakeholders to provide health care and address the burden of TB among children
In a high-security building in Kampala, Uganda, a man leads a group of sleuths investigating a potential killer. While they may go about their work with the meticulousness of police detectives, they are actually a different type of investigator. Professor Moses Joloba, Director of Uganda's Supranational Reference Laboratory, leads his team to pursue TB – the world’s leading killer among infectious diseases. The disease killed more than 1.6 million people around the world in 2017.
Mwadawa Iddi was suffering from a painful disease, but she did not know what it was. She was 82 and living alone in her small village, which restricted her movement and the ability to seek treatment. She was on the verge of losing hope when Rashid Gora, a community health worker, found her.
• Tuberculosis is now the leading cause of death from infectious disease, with 1.3 million deaths per year, not including HIV co-infections.
• Globally, the rate of decline in TB incidence has been slow, at 2 percent per year from 2000 to 2016, mainly due to low case notification. An estimated 4.1 million people with TB have been missed every year and contribute to ongoing transmission. To achieve the milestones set in the End TB Strategy, we must accelerate the rate of reduction to 4-5 percent each year by 2020.
We are making extraordinary progress in the fight against HIV, tuberculosis and malaria, but far too many people are still dying from these diseases, which are fully preventable. To end these epidemics, we need increased investment, accelerated innovation and a relentless focus on impact.
Le partenariat du Fonds mondial a sauvé 27 millions de vies
PARIS – Le partenariat du Fonds mondial a sauvé 27 millions de vies selon un rapport publié aujourd’hui qui fait état de formidables avancées dans le combat mené à l’échelle mondiale contre le VIH, la tuberculose et le paludisme. Parallèlement à ces progrès, le rapport met également en évidence les nouvelles menaces qui pèsent sur les efforts déployés pour en finir avec ces épidémies.
Voici les grands résultats obtenus en 2017 dans les pays où le Fonds mondial investit :
Global Fund Partnership has Saved 27 Million Lives
PARIS – The Global Fund to Fight AIDS, Tuberculosis and Malaria released a report today demonstrating that 27 million lives have been saved by the Global Fund partnership. The report shows tremendous progress that has been achieved by efforts to end the epidemics, while highlighting new threats.
The Results Report 2018 includes key annual results achieved in countries where the Global Fund invests:
17.5 million people received antiretroviral therapy for HIV.
Les personnes et les communautés les plus touchées par le VIH, la tuberculose et le paludisme apportent des contributions essentielles à la mission du Fonds mondial d’en finir avec ces trois épidémies tout en mettant en place des systèmes de santé plus forts et plus réactifs.
The individuals and communities most affected by HIV, TB and malaria make critical contributions to the Global Fund’s mission to accelerate the end of the three diseases as epidemics, while building stronger, more responsive systems for health.
Community voices and leadership in governance, implementation and oversight of Global Fund-supported programs is essential to achieving lasting impact.
AMSTERDAM – At the International AIDS Conference, the Global Fund to Fight AIDS, Tuberculosis and Malaria joined efforts to accelerate the end of the HIV epidemic, linking civil society, scientific experts and policymakers from all over the world on the conference theme of breaking barriers and building bridges.
With broad agreement that global health efforts are not on track to end the epidemic by 2030, partners called for bold political leadership to mobilize more funding, overcome human rights barriers and gender inequalities, and build stronger health systems.
In 2000, AIDS, tuberculosis and malaria appeared to be unstoppable. In many countries, AIDS devastated an entire generation, leaving countless orphans and shattered communities. Malaria killed young children and pregnant women unable to protect themselves from mosquitoes or access lifesaving medicine. Tuberculosis unfairly afflicted the poor, as it had for millennia.
GENÈVE – Le Fonds mondial de lutte contre le sida, la tuberculose et le paludisme a conclu des accords-cadres pluriannuels avec des fournisseurs de médicaments anti-VIH, grâce auxquels il sera possible d’économiser 324 millions de dollars US d’ici la fin de 2021, tandis que plus de quatre millions de personnes auront la garantie de recevoir des médicaments essentiels.
Geneva, 16 July 2018 – The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and the International Committee of the Red Cross (ICRC) met Monday to announce a collaboration agreement focused on providing better care to individuals and communities burdened by these diseases in hard-to-reach conflict-affected areas and detention centres.
16 July 2018
GENEVA – The Global Fund to Fight AIDS, Tuberculosis and Malaria has signed multi-year framework agreements with suppliers of HIV medication that will save US$324 million by the end of 2021 and secure the supply of lifesaving drugs for over 4 million people.
Countries in the Pacific region are important implementers of Global Fund grants. Sustained commitment and successful partnerships are leading to transformative results. The Global Fund is partnering with governments, medical experts, advocates, civil society and communities affected by HIV, TB and malaria to fight the three diseases and build resilient and sustainable systems for health. As of April 2018, the Global Fund partnership has invested a total of US$341 million in 14 island countries in the Pacific region.
The Global Fund is partnering with governments, medical experts, advocates, civil society and people living with HIV, TB and malaria to fight the three diseases in the Indo-Pacific region. A total of US$9.2 billion has been invested in treating and preventing the diseases, and to building more resilient and sustainable systems for health. More than one-third of total Global Fund financial resources have been spent in the Indo-Pacific region.
Francophone countries are a strategic area of focus for the Global Fund.
The sustained commitment of francophone nations, coupled with strategic partnerships and increased domestic financing, has led to transformative results.
France, Belgium, Switzerland, Luxembourg and Canada joined the Global Fund to fight against AIDS, tuberculosis and malaria, three diseases that seemed unstoppable a decade ago. To date, the Global Fund has invested approximately US$8 billion in francophone countries which make up approximately 20 percent of the overall Global Fund portfolio.
Les pays francophones forment une zone d’intervention stratégique du Fonds mondial.
L’engagement soutenu des nations francophones, conjugué à des partenariats stratégiques et à l’augmentation des financements nationaux, a donné des résultats porteurs de changements.
The Global Fund is partnering with governments, medical experts, advocates, civil society and people living with HIV, TB and malaria to fight the three diseases in the Asia-Pacific region.1 A total of US$6.6 billion has been invested in treating and preventing the diseases in the Asia-Pacific region, and in building more resilient and sustainable systems for health. This equates to approximately one-quarter of total Global Fund financial resources.